or
forgot password

    • cancer clinical trials in north charleston, SC

    • Docetaxel and Vinorelbine Plus Filgrastim in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
    Trident Palmetto Hematology/Oncology
    North Charleston, South Carolina 29406
    Lung Cancer
    PS-341 (VELCADE™) Versus High-Dose Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma
    Trident Palmetto Hematology/Oncology
    North Charleston, South Carolina 29406
    Multiple Myeloma
    A Study of PS-341 Given to Patients With Multiple Myeloma Who Experienced Progressive Disease After Receiving Dexamethasone in M34101-039
    Trident Palmetto Hematology/Oncology
    North Charleston, South Carolina 29406
    Multiple Myeloma
    Novel Epothilone Plus Capecitabine Versus Capecitabine Alone in Patients With Advanced Breast Cancer
    Local Institution
    North Charleston, South Carolina
    Breast Cancer, Metastases
    Study of BMS-354825 (Dasatinib) in Patients With Chronic Myeloid Leukemia Who Are Either Resistant or Intolerant to Imatinib
    Local Institution
    North Charleston, South Carolina
    Chronic Myeloid Leukemia, Philadelphia-Positive Myeloid Leukemia
    Dasatinib (BMS-354835) Versus Imatinib Mesylate in Subjects With Chronic Myeloid Leukemia
    Local Institution
    North Charleston, South Carolina
    Chronic Myeloid Leukemia, Philadelphia-Positive Myeloid Leukemia
    A Study of Dasatinib in Patients With Chronic Myelogenous Leukemia Who Are Resistant or Intolerant of Imatinib Mesylate
    Local Institution
    North Charleston, South Carolina
    Leukemia, Myeloid, Chronic, Leukemia, Lymphocytic, Acute, L2
    A Study of Tanespimycin (KOS-953) in Patients With Relapsed-refractory Multiple Myeloma
    Local Institution
    North Charleston, South Carolina
    Multiple Myeloma